Ligandrol Impurities | Pharmaffiliates

Ligandrol

Ligandrol is a novel nonsteroidal oral selective androgen receptor modulator for treatment of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and under development by Viking Therapeutics. Reference standards of Ligandrol API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Ligandrol - API Standards 
    [catalogue_number] => PA 65 26000
    [category_ids] => ,70,75,76,78,82,
    [chemical_name] => 
    [weight] => 351.29
    [form] => C16H15F6NO
    [cas] => 1165910-22-4
    [pslug] => 1165910-22-4-ligandrol-api-pa6526000
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 65 26000

Ligandrol - API Standards


  • Catalogue No.:PA 65 26000

  • CAS :

    1165910-22-4

  • Molecular Formula : C16H15F6NO

  • Molecular Weight : 351.29